Altre lingue Diagonal Bio AB

Azioni

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 18:00:00 16/07/2024			Variaz. 5gg	Var. 1 gen.
0,026 ^SEK	-2,26%		-8,13%	-92,63%

11/06	Diagonal Bio AB (publ) approva il membro del Consiglio di Amministrazione Karin Wehlin che rifiuta la rielezione	CI
31/05	Diagonal Bio AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Bulletin from the Annual General Meeting on 11 June 2024 in Diagonal Bio AB	11/06
Diagonal Bio AB Approves the Board Member Karin Wehlin Declines Re-Election	11/06
Diagonal Bio AB first quarter (Q1 2024)	31/05
Diagonal Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	31/05
Diagonal Bio appoints new CFO	23/05
Diagonal Bio AB Appoints Fata Mrsic as Chief Financial Officer, Effective June 14, 2024	23/05
Diagonal Bio announces strategic pilot study with Löberöds Hästklinik	15/05
Diagonal Bio Announces Strategic Pilot Study with Löberöds Hästklinik	15/05
Diagonal Bio AB Annual Report 2023	15/05
Diagonal Bio AB announces last day of trading in BTU and first day of trading in TO 1	07/05
Diagonal Bio AB announces outcome of rights issue	24/04
Diagonal Bio AB publish - White paper	16/04
Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand	10/04
The subscription period in Diagonal Bio AB rights issue commences today	08/04
Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic	05/04
Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic	05/04
Diagonal Bio AB Announces Successful Pilot Study Results	05/04
Diagonal Bio AB publishes a prospectus because of upcoming rights issue	03/04
Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB	02/04
Diagonal Bio Makes Interim CEO Permanent	29/02

Non ci sono risultati per questa ricerca